On March 18, 2026, LeonaBio, Inc. held a special meeting where stockholders approved several key proposals, including the 2026 Equity Incentive Plan and increasing authorized shares from 90 million to 400 million. Approximately 79.63% of shares were represented at the meeting, demonstrating strong support for these initiatives.